Iwayama T, Leung P S, Rowley M, Munoz S, Nishioka M, Nakagawa T, Dickson E R, Coppel R L, Mackay I R, Gershwin M E
First Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Int Arch Allergy Immunol. 1992;99(1):28-33. doi: 10.1159/000236331.
Primary biliary cirrhosis (PBC) has been described among various ethnic and racial populations in all parts of the world. However, the incidence and prevalence of PBC varies considerably in different geographic areas. It has the highest frequency in Northern Europe, is considerably lower in Japan and still lower in other parts of Asia. There has not hitherto been a detailed immunological profile of antimitochondrial antibodies according to geographic region. We have used recombinant or purified preparations from the 2-oxo-acid dehydrogenase enzyme complexes, the major mitochondrial autoantigens in PBC (PDC-E2, BCOADC-E2, OGDC, protein X and PDC-E1 alpha) to compare the reactivity of sera from either similarly staged sera from Japanese (n = 23) or American-Caucasian patients (n = 39) with PBC. In all cases, the first available sera following diagnosis was selected. Interestingly, only 65% of Japanese patients reacted by ELISA with PDC-E2 compared with more than 95% of the North American group. Moreover, the level of enzyme-inhibitory antibodies to PDC was lower in the Japanese. Our findings prompt the need for characterization of specific susceptibility genes and environmental factors in various parts of the world to clarify the etiology of PBC.
原发性胆汁性肝硬化(PBC)在世界各地的不同种族人群中均有报道。然而,PBC的发病率和患病率在不同地理区域差异很大。在北欧发病率最高,在日本则低得多,在亚洲其他地区更低。迄今为止,尚无根据地理区域划分的抗线粒体抗体详细免疫特征。我们使用了来自2-氧代酸脱氢酶复合物的重组或纯化制剂,这些是PBC中的主要线粒体自身抗原(丙酮酸脱氢酶复合物E2亚单位、支链2-氧代酸脱氢酶复合物E2亚单位、2-氧代戊二酸脱氢酶复合物、蛋白X和丙酮酸脱氢酶复合物E1α亚单位),以比较日本(n = 23)或美国白种人PBC患者(n = 39)处于相似疾病阶段的血清反应性。在所有情况下,均选择诊断后首次获得的血清。有趣的是,通过酶联免疫吸附测定(ELISA),只有65%的日本患者对丙酮酸脱氢酶复合物E2有反应,而北美组这一比例超过95%。此外,日本患者中针对丙酮酸脱氢酶复合物的酶抑制性抗体水平较低。我们的研究结果表明,有必要对世界不同地区的特定易感基因和环境因素进行表征,以阐明PBC的病因。